导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 45.44% | 53/1050 |
| 近一周 | -2.73% | 706/1104 |
| 近一月 | -3.19% | 370/1102 |
| 近一季 | -17.42% | 912/1092 |
| 近半年 | 46.14% | 21/1070 |
| 近一年 | 58.14% | 53/1018 |
| 近两年 | 240.18% | 36/926 |
| 近三年 | 177.77% | 39/834 |
| 成立以来 | 152.45% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.73% 360/1070 |
95.13% 64/1101 |
- - |
- - |
| 2025 | 68.93% 65/1065 |
-14.98% 1003/1014 |
6.71% 203/1038 |
69.56% 12/1050 |
9.81% 48/1065 |
| 2024 | 20.25% 89/1011 |
3.87% 136/960 |
-4.00% 571/983 |
10.18% 611/991 |
9.46% 64/1011 |
| 2023 | -22.09% 725/952 |
-1.22% 678/880 |
9.77% 20/895 |
-19.26% 853/915 |
-11.00% 882/952 |
| 2022 | -33.04% 679/867 |
-20.94% 572/773 |
3.53% 606/806 |
-1.79% 28/845 |
-16.70% 838/867 |
| 2021 | 17.49% 164/740 |
-11.32% 511/580 |
37.17% 27/659 |
-2.88% 287/704 |
-0.55% 461/740 |
| 2020 | 65.13% 165/554 |
16.63% 15/419 |
30.33% 127/466 |
-3.23% 450/517 |
12.26% 282/554 |
| 2019 | 77.24% 15/410 |
37.11% 103/1146 |
-4.95% 708/1228 |
23.75% 7/390 |
9.90% 162/410 |
| 2018 | -38.86% 274/349 |
- - |
-19.11% 894/990 |
-16.82% 959/1000 |
-9.35% 247/1080 |
| 2017 | 21.24% 78/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国联安科技动力 VS. 东吴新产业精选股票A(580008) |